查看所有供应商和价格请点击:
1312305-12-6生产厂家
1312305-12-6价格
化源商城直购
FGFR3
[1]. Andrea Necchi, et al. Fierce-21: Phase II study of vofatmab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC). Journal of Clinical Oncology 2019 37:7_suppl, 409-409.